Ceftizoxime Production Cost Reports

The report provides a detailed analysis essential for establishing a ceftizoxime production plant. It encompasses all critical aspects necessary for ceftizoxime production, including the cost of ceftizoxime production, ceftizoxime plant cost, ceftizoxime production costs, and the overall ceftizoxime production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a ceftizoxime production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Ceftizoxime is a third-generation cephalosporin antibiotic mainly used to treat a variety of bacterial infections. It belongs to the cephalosporin group of antibiotics and is primarily used to treat a variety of serious bacterial infections caused by a wide range of gram-positive and gram-negative bacteria. It is widely used for treating bacterial infections of the lower respiratory tract, urinary tract, bones, joints, skin, soft tissues, and abdominal infections.  It is also sometimes used after surgeries to prevent infections. It is also to manage lower respiratory tract infections like pneumonia, complicated urinary tract infections, skin and soft tissue infections, bone and joint infections such as osteomyelitis, intra-abdominal infections, and gonorrhoea. It works by stopping the growth of bacteria and is usually given by injection in hospitals or clinics. It is also applied in hospital settings for managing infections in patients with weakened immune systems.

The demand for ceftizoxime is predominantly driven by its application as an oral antibiotic for the treatment of serious bacterial infections caused by susceptible microorganisms, which supports its market growth. Its application as injectable formulations for the treatment of respiratory tract infections, urinary tract infections, skin infections, and infections of the bloodstream significantly boosts its demand in the pharmaceutical industry.

Its demand in clinical treatment and pharmaceutical production further boosts its market expansion. Its application as a drug in the treatment of serious conditions, including septicemia, meningitis, and pelvic inflammatory disease, particularly in compromised patients, also fuels its demand in the medical sector. Industrial ceftizoxime procurement is influenced by major factors such as the cost and accessibility of cephalosporin intermediates, regulatory certifications, and adherence to good production practices (GMP). Moreover, advancements in drug delivery systems, supply chain reliability, antimicrobial stewardship programs, and compliance with environmental and safety standards also influence its procurement strategies on a global scale.

Raw Material for Ceftizoxime Production

According to the ceftizoxime production plant project report, the major raw materials for ceftizoxime production include 4-nitrobenzyl ester of 3-hydroxy-7-(2-phenylacetamido)-3-cefem-4-carboxylic acid, phosphorus pentachloride, and 2-(2-formamido-4-thiazolyl)-2-methoxyiminoacetic acid.

Production Process of Ceftizoxime

The extensive ceftizoxime production cost report consists of the following industrial production process:

1. Production via Chemical Synthesis: The production process of ceftizoxime begins with the 4-nitrobenzyl ester of 3-hydroxy-7-(2-phenylacetamido)-3-cefem-4-carboxylic acid. The double bond in this molecule is reduced using sodium borohydride to form a 3-cefam derivative, which is then acetylated and subsequently deacetylated to remove the hydroxyl group. Then, the obtained product undergoes treatment with phosphorus pentachloride, followed by methanolysis, which removes the acyl group on the amide and produces a 7-amino intermediate. This amino group is protected through silylation, and then acylated using an acid chloride derived from 2-(2-formamido-4-thiazolyl)-2-methoxyiminoacetic acid. The resulting 4-nitrobenzyl ester is then removed via hydrogenation using palladium on carbon, which forms the free acid. Finally, hydrolysis of the formamide group using hydrogen chloride in methanol gives ceftizoxime as the desired product.

Ceftizoxime is a semisynthetic third-generation cephalosporin antibiotic belonging to the beta-lactam class of antibacterial agents. It appears as a white to almost white crystalline powder. The molecular formula of the compound is C13H13N5O5S2, and its molar mass is 383.4 g/mol. The compound decomposes at its melting point, which is approximately 227 degree Celsius. It is practically insoluble in water and ethanol but soluble in dimethyl sulfoxide at approximately 76 mg/mL. However, its sodium salt form is freely soluble in water, which is the formulation used for parenteral administration. The compound is highly resistant to a broad spectrum of beta-lactamases and exhibits activity against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. Ceftizoxime was approved by the FDA and marketed under the brand name Cefizox. The compound should be stored at 2–8 degree Celsius to maintain stability.